Targeting EphA3 inhibits cancer growth by disrupting the tumor stromal microenvironment

Cancer Research

Volumn 74, Issue 16, 2014, Pages 4470-4481

  Vail, Mary E ^a   Murone, Carmel ^b   Tan, April ^a   Hii, Linda ^a   Abebe, Degu ^a   Janes, Peter W ^a   Lee, Fook Thean ^b   Baer, Mark ^c   Palath, Varghese ^c   Bebbington, Christopher ^c   Yarranton, Geoffrey ^c   Llerena, Carmen ^a   Garic, Slavisa ^a   Abramson, David ^a   Cartwright, Glenn ^b   Scott, Andrew M ^b,d   Lackmann, Martin ^a  

^a MONASH UNIVERSITY   (Australia)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

^c KaloBios Inc   (United States)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EPHA3 PROTEIN, HUMAN; EPHA3 PROTEIN, MOUSE; EPHRIN RECEPTOR A3; MONOCLONAL ANTIBODY; PROTEIN TYROSINE KINASE;

AGONISTS; ANIMAL; APOPTOSIS; BIOSYNTHESIS; CELL TRANSFORMATION; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; HEK293 CELL LINE; HUMAN; IMMUNOLOGY; METABOLISM; MOLECULARLY TARGETED THERAPY; MOUSE; NUDE MOUSE; PATHOLOGY; SIGNAL TRANSDUCTION; STROMA CELL; TUMOR CELL LINE; TUMOR MICROENVIRONMENT;

ANIMALS; ANTIBODIES, MONOCLONAL; APOPTOSIS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMANS; MICE; MICE, NUDE; MOLECULAR TARGETED THERAPY; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, EPHA3; SIGNAL TRANSDUCTION; STROMAL CELLS; TUMOR MICROENVIRONMENT;

EID: 84905970522     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-14-0218     Document Type: Article

References (46)

1. Hanahan D, Coussens LM. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell 2012;21:309-22.
2. McAllister SS, Weinberg RA. Tumor-host interactions: a far-reaching relationship. J Clin Oncol 2010;28:4022-8.
3. Gao D, Mittal V. The role of bone-marrow-derived cells in tumor growth, metastasis initiation and progression. Trends Mol Med 2009;15:333-43.
4. Boyd AW, Bartlett PF, Lackmann M. Therapeutic targeting of EPH receptors and their ligands. Nat Rev Drug Discov 2014;13:39-62.
5. Pasquale EB. Eph receptors and ephrins in cancer: bidirectional signalling and beyond. Nat Rev Cancer 2010;10:165-80.
6. Nievergall E, Lackmann M, Janes PW. Eph-dependent cell-cell adhesion and segregation in development and cancer. Cell Mol Life Sci 2012;69:1813-43.
7. Noren NK, Foos G, Hauser CA, Pasquale EB. The EphB4 receptor suppresses breast cancer cell tumorigenicity through an Abl-Crk pathway. Nat Cell Biol 2006;8:815-25. (Pubitemid 44151584)
8. Genander M, Halford MM, Xu NJ, Eriksson M, Yu Z, Qiu Z, et al. Dissociation of EphB2 signaling pathways mediating progenitor cell proliferation and tumor suppression. Cell 2009;139:679-92.
9. Day BW, Stringer BW, Al-Ejeh F, Ting MJ, Wilson J, Ensbey KS, et al. EphA3 maintains tumorigenicity and is a therapeutic target in glioblastoma multiforme. Cancer Cell 2013;23:238-48.
10. Macrae M, Neve RM, Rodriguez-Viciana P, Haqq C, Yeh J, Chen C, et al. A conditional feedback loop regulates Ras activity through EphA2. Cancer Cell 2005;8:111-8. (Pubitemid 41132740)
11. Kilpatrick TJ, Brown A, Lai C, Gassmann M, Goulding M, Lemke G. Expression of the Tyro4/Mek4/Cek4 gene specifically marks a subset of embryonic motor neurons and their muscle targets. Mol Cell Neurosci 1996;7:62-74. (Pubitemid 26088260)
12. Oates AC, Lackmann M, Power MA, Brennan C, Down LM, Do C, et al. An early developmental role for eph-ephrin interaction during vertebrate gastrulation. Mech Dev 1999;83:77-94. (Pubitemid 29302083)
13. Gallarda BW, Bonanomi D, Muller D, Brown A, Alaynick WA, Andrews SE, et al. Segregation of axial motor and sensory pathways via heterotypic trans-axonal signaling. Science 2008;320:233-6. (Pubitemid 351521419)
14. Stephen LJ, Fawkes AL, Verhoeve A, Lemke G, Brown A. A critical role for the EphA3 receptor tyrosine kinase in heart development. Dev Biol 2007;302:66-79. (Pubitemid 46096924)
15. Chiari R, Hames G, Stroobant V, Texier C, Maillere B, Boon T, et al. Identification of a tumor-specific shared antigen derived from an Eph receptor and presented to CD4 T cells on HLA class II molecules. Cancer Res 2000;60:4855-63.
16. Xi HQ, Wu XS, Wei B, Chen L. Aberrant expression of EphA3 in gastric carcinoma: correlation with tumor angiogenesis and survival. J Gastroenterol 2012;47:785-94.
17. Keane N, Freeman C, Swords R, Giles FJ. EPHA3 as a novel therapeutic target in the hematological malignancies. Expert Rev Hematol 2012;5:325-40.
18. Ashton JM, Balys M, Neering SJ, Hassane DC, Cowley G, Root DE, et al. Gene sets identified with oncogene cooperativity analysis regulate in vivo growth and survival of leukemia stem cells. Cell Stem Cell 2012;11:359-72.
19. Lisabeth EM, Fernandez C, Pasquale EB. Cancer somatic mutations disrupt functions of the EphA3 receptor tyrosine kinase through multiple mechanisms. Biochemistry 2012;51:1464-75.
20. Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, et al. The consensus coding sequences of human breast and colorectal cancers. Science 2006;314:268-74. (Pubitemid 44571966)
21. Ding L, Getz G, Wheeler DA, Mardis ER, McLellan MD, Cibulskis K, et al. Somatic mutations affect key pathways in lung adenocarcinoma. Nature 2008;455:1069-75.
22. Balakrishnan A, Bleeker FE, Lamba S, Rodolfo M, Daniotti M, Scarpa A, et al. Novel somatic and germline mutations in cancer candidate genes in glioblastoma, melanoma, and pancreatic carcinoma. Cancer Res 2007;67:3545-50. (Pubitemid 46762135)
23. Vearing C, Lee FT, Wimmer-Kleikamp S, Spirkoska V, To C, Stylianou C, et al. Concurrent binding of anti-EphA3 antibody and ephrin-A5 amplifies EphA3 signaling and downstream responses: potential as EphA3-specific tumor-targeting reagents. Cancer Res 2005;65:6745-54. (Pubitemid 41060712)
24. Lancet J, Wei AH, Durrant ST, Hertzberg MS, Swords RT, Lewis ID, et al. A phase I study of KB004, a novel non-fucosylated humaneered® antibody, targeted against the receptor tyrosine kinase EphA3, in advanced hematologic malignancies [abstract]. In: Proceedings of the 55th ASH Annual Meeting and Exposition; 2013 Dec 7-10; New Orleans, LA. Washington, DC: ASH; 2013. Abstract nr 3838.
25. Palmieri M, Nowell CJ, Condron M, Gardiner J, Holmes AB, Desai J, et al. Analysis of cellular phosphatidylinositol (3,4,5)-trisphosphate levels and distribution using confocal fluorescent microscopy. Anal Biochem 2010;406:41-50.
26. di Tomaso E, Capen D, Haskell A, Hart J, Logie JJ, Jain RK, et al. Mosaic tumor vessels: cellular basis and ultrastructure of focal regions lacking endothelial cell markers. Cancer Res 2005;65:5740-9. (Pubitemid 40911177)
27. Zipfel WR, Williams RM, Webb WW. Nonlinear magic: multiphoton microscopy in the biosciences. Nat Biotechnol 2003;21:1369-77. (Pubitemid 37356624)
28. Russel ABM, Abramson D, Bethwaite B, Minh Ngoc D, Enticott C, Firth S, et al. An abstract virtual instrument system for high throughput automatic microscopy. ICCS 2010;1:545-54.
29. Boyd AW, Ward LD, Wicks IP, Simpson RJ, Salvaris E, Wilks A, et al. Isolation and characterization of a novel receptor-type protein tyrosine kinase (hek) from a human pre-B cell line. J Biol Chem 1992;267:3262-7.
30. Smith FM, Vearing C, Lackmann M, Treutlein H, Himanen J, Chen K, et al. Dissecting the EphA3/Ephrin-A5 interactions using a novel functional mutagenesis screen. J Biol Chem 2004;279:9522-31. (Pubitemid 38296020)
31. Vearing CJ, Lackmann M. "Eph receptor signalling; dimerisation just isn't enough". Growth Factors 2005;23:67-76. (Pubitemid 41656872)
32. Lawrenson ID, Wimmer-Kleikamp SH, Lock P, Schoenwaelder SM, Down M, Boyd AW, et al. Ephrin-A5 induces rounding, blebbing and de-adhesion of EphA3- expressing 293T and melanoma cells by CrkII and Rho-mediated signalling. J Cell Sci 2002;115:1059-72. (Pubitemid 34257389)
33. Morikawa S, Mabuchi Y, Kubota Y, Nagai Y, Niibe K, Hiratsu E, et al. Prospective identification, isolation, and systemic transplantation of multipotent mesenchymal stem cells in murine bone marrow. J Exp Med 2009;206:2483-96.
34. Zhu H, Guo ZK, Jiang XX, Li H, Wang XY, Yao HY, et al. A protocol for isolation and culture of mesenchymal stem cells from mouse compact bone. Nat Protoc 2010;5:550-60.
35. Batlle E, Bacani J, Begthel H, Jonkheer S, Gregorieff A, van de Born M, et al. EphB receptor activity suppresses colorectal cancer progression. Nature 2005;435:1126-30. (Pubitemid 40910522)
36. Gale NW, Holland SJ, Valenzuela DM, Flenniken A, Pan L, Ryan TE, et al. Eph receptors and ligands comprise two major specificity subclasses and are reciprocally compartmentalized during embryogenesis. Neuron 1996;17:9-19. (Pubitemid 26251587)
37. Genander M, Holmberg J, Frisen J. Ephrins negatively regulate cell proliferation in the epidermis and hair follicle. Stem Cells 2010;28:1196-205.
38. Ellis LM, Hicklin DJ. VEGF-targeted therapy: mechanisms of anti-tumour activity. Nat Rev Cancer 2008;8:579-91.
39. Batlle E, Wilkinson DG. Molecular mechanisms of cell segregation and boundary formation in development and tumorigenesis. Cold Spring Harb Perspect Biol 2012;4:a008227.
40. Cortina C, Palomo-Ponce S, Iglesias M, Fernandez-Masip JL, Vivancos A, Whissell G, et al. EphB-ephrin-B interactions suppress colorectal cancer progression by compartmentalizing tumor cells. Nat Genet 2007;39:1376-83. (Pubitemid 350034995)
41. Xi HQ, Zhao P. Clinicopathological signi ficance and prognostic value of EphA3 and CD133 expression in colorectal carcinoma. J Clin Pathol 2011;64:498-503.
42. Bianco P, Robey PG, Simmons PJ. Mesenchymal stem cells: revisiting history, concepts, and assays. Cell Stem Cell 2008;2:313-9. (Pubitemid 351467394)
43. Lin CS, Lue TF. Defining vascular stem cells. Stem Cells Dev 2013;22:1018-26.
44. Martin-Rendon E, Hale SJ, Ryan D, Baban D, Forde SP, Roubelakis M, et al. Transcriptional profiling of human cord blood CD133+ and cultured bone marrow mesenchymal stem cells in response to hypoxia. Stem Cells 2007;25:1003-12. (Pubitemid 46572598)
45. Kawakami Y, Uchiyama Y, Rodriguez Esteban C, Inenaga T, Koyano-Nakagawa N, Kawakami H, et al. Sall genes regulate region-specific morphogenesis in the mouse limb by modulating Hox activities. Development 2009;136:585-94.
46. Arthur A, Zannettino A, Panagopoulos R, Koblar SA, Sims NA, Stylianou C, et al. EphB/ephrin-B interactions mediate human MSC attachment, migration and osteochondral differentiation. Bone 2011;48:533-42.